RxDoctor Payments Data

Paul Woody, DO

Family Medicine · Dahlonega, GANPI 1447605936

Payments from drug & device makers

$5,479in general payments, 2019–2025

Across 339 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$369
  • Novo Nordisk$351
  • Otsuka America Pharmaceutical, Inc.$294
  • Novartis$277
  • Grifols USA, LLC$197
  • plus $3K from 44 others

What the payments were for

  • Food & beverage$5,40299%
  • Education$771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,479 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$62,610
Medicare patients
168
Services billed
2,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide47$51,158
MounjaroTirzepatide36$38,649
OzempicSemaglutide31$34,445
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$31,079
EliquisApixaban34$26,856
TrulicityDulaglutide18$22,963
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$17,205
FarxigaDapagliflozin Propanediol18$10,374
RestasisCyclosporine11$7,146
BrilintaTicagrelor12$5,426
Sumatriptan Succinate12$2,827
Albuterol Sulfate HfaAlbuterol Sulfate110$2,529
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl12$1,763
Fluticasone Propionate121$1,526
PaxlovidNirmatrelvir/Ritonavir15$1,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$351$85,60378 claims
Lilly USA, LLCMounjaro, Trulicity$196$61,61154 claims
AstraZenecaBreztri Aerosphere, Farxiga, Brilinta$174$33,00552 claims
GSKTrelegy Ellipta$189$31,07940 claims
PfizerEliquis, Paxlovid$195$28,28549 claims
AbbVieRestasis$1,073$7,14611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Dahlonega

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →